|
|
|
|
LEADER |
01722nam a2200277 u 4500 |
001 |
EB002001794 |
003 |
EBX01000000000000001164695 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Kim, Joanne
|
245 |
0 |
0 |
|a Proton beam therapy for the treatment of cancer in children and adults
|h Elektronische Ressource
|b a health technology assessment
|c clinical authors, Dr. Joanne Kim, Charlotte Wells, Sara Khangura, Christine Alexander, Dr. Sohail Mulla, Kelly Farrah ; economic authors, Dr. Mike Paulden, Dr. Bernice Tsoi ; patient preferences and experiences authors, Dr. Deirdre DeJean ; ethics author, Dr. Katherine Duthie ; implementation authors, Barbara Greenwood Dufour
|
260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2017, August 2017
|
300 |
|
|
|a 1 PDF file (210 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Medical Tourism
|
653 |
|
|
|a Neoplasms / radiotherapy
|
653 |
|
|
|a Proton Therapy
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH health technology assessment
|
500 |
|
|
|a "PROSPERO Registration Number: CRD42017061033."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK531691
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The objective of this health technology assessment (HTA) is to inform the policy question through an assessment of the clinical effectiveness and safety, budget impact, patient perspectives and experiences, ethical issues, and implementation issues of proton beam therapy (PBT) for the treatment of cancer in children and adults
|